Back to the articles list | Back to browse issues page

XML Print

Challenges and diagnostic insights in extrapulmonary tuberculosis: A commentary on experiences from a high-burden region in Iran
Sadeghali Azimi
Infectious Diseases Research Center, Jorjani Clinical sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran , drsazimi@yahoo.com
Abstract:   (122 Views)
Editorial
Keywords: Editorial
     
Research Article: Editorial Material | Subject: Others
Received: 2026/03/1 | Accepted: 2026/04/1
References
1. Daneshi S, Mehni EB, Kamali M, Barfar E, Barahouei FB, Hushmandi K,et al. Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review. BMC Infect Dis. 2025;25(1):1004. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Mohajan H. Tuberculosis is a fatal disease among some developing countries of the world. MPRA. 2014;3(1):18-31. [View at Publisher] [Google Scholar]
3. Azimi S, Bashardoust B, Mohammadi M. Prospects and Research Trends of Tuberculosis in Iran: A Bibliometric Study With a Science Mapping Approach. Interdiscip Perspect Infect Dis. 2025;2025(1):7594073. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Honarvar MR, Charkazi A, Mirkarimi K, Sheikhi M, Kamalinia HR, Arbabi ER. Eleven year epidemiological study of tuberculosis in Golestan Province, Northern of Iran. Iran J Public Health. 2020;49(3);563-9. [View at Publisher] [DOI] [Google Scholar]
5. Sharma SK, Mohan A, Kohli M. Extrapulmonary tuberculosis. Expert Rev Respir Med. 2021;15(7):931-48. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Otieno JA, Were LM, Lutje V, Scandrett K, Takwoingi Y, Ochodo EA. Impact of rapid nucleic acid amplification tests for tuberculosis on patient outcomes. Cochrane Database Syst Rev. 2025;12(12):Cd016194. [View at Publisher] [DOI] [PMID] [Google Scholar]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.